Definium Therapeutics (Fka Mind Medicine (Mindmed) Inc.)
MD · 8 filings, 2025
Lobbying spend · 2025
$370K
to shape legislation
About the organization
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Alcohol and Drug Abuse · Budget/Appropriations · Medicare/Medicaid · Pharmacy · Tariff (miscellaneous tariff bills) · Veterans
2Through these firms · 2
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)THE CONAFAY GROUP, LLC
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews